Navigation Links
Jingle All the Way With a Lean and Fit Santa!

Glasgow: Its time to be merry, for Christmas is fast approaching. The Santa Claus, who are so much a part of the Christmas celebration, spreading cheer// all around, are observed to be grossly overweight, and certainly not in the pink of health.

Doctors in Scotland have explained how most of the Santa, ringing in the Christmas season at departmental stores, are frightfully fat, and need to diet on a war footing. It is imperative they knock off atleast 7 inches at their waist, if they want to be around for next Christmas. The average waist size of Santas this season was an ample 47 inches.

Health guidelines have recommended that a waist circumference of above 40 inches for men and 35 inches for women, calls for a reduction in the fat around the abdomen, as it increases the risk of lifestyle diseases.

Dr. Miles Fisher, consultant physician at Glasgow Royal Infirmary explained how abdominal obesity, which is also called as "central obesity", enhances the risk of heart disease and type 2 diabetes.

So Santa Claus had better shape up or risk getting shipped out!
'"/>




Page: 1

Related medicine news :

1. Almonds As Effective As Certain Drugs In Lowering Cholesterol
2. Certain Food Beneficial for the Heart
3. Sunlight Could Be Beneficial For Certain Types Of Cancer
4. Calcium Supplements May Not Be Useful After A Certain Threshold Is Achieved
5. Small Doses Of Radiation Can Help Certain Lung Cancer Patients
6. Effects Of Certain Food Related To Single Pain Receptors
7. Spices Could Be Employed To Treat Certain Cancers
8. Certain antidepressant drugs associated with pronounced suicidal tendencies
9. Elements In Grape fruit Juice Combine Lethally with Certain Drugs, leading to potentially dangerous side effects, study.
10. John Hopkins Develops An Online Tool To Help In Research Of Certain Rare Diseases
11. Hearing May be affected by Certain Hormone Replacement Therapies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Jingle All the Way With Lean and Fit Santa

(Date:11/23/2009).../PRNewswire/--Howistheeconomyaffectingpeople,swell...llnessonWellness&theEconomy,theeconomyismaking...thylifestyleofexerciseanddiettoonethatismoreinward...Thesurvey,smostdramaticfindingwasthechangeinconsum...nalfocusonhealthandwellbeingtotoday,smorerelevantc...
(Date:11/23/2009)... impair breathing, protein may be the cause , ...researchers say they,ve identified a protein that...0 percent of people with chronic sinusitis. , T...inusitis, a constant irritation and swelling of th...f sinus tissue -- can block the sinus passages and...
(Date:11/23/2009)... Exposure shortly after birth to ambient metals fr...s from diesel emissions are associated with respir...ding to a new study by researchers at the Columbia...) at Columbia University,s Mailman School of Publi...ffects of exposure to airborne metals in this very...
(Date:11/23/2009)...a graduate student Jennifer Heys wants to make her...n Ugandan communities about contraception. , He...r desire to bear more children, was read by expert...t the International Conference on Family Planning ...chool of Public Health, spent six months interview...
(Date:11/23/2009)... Plastic and Reconstructive Surgery...In Brief ...dated on the most current journal news from the Am...of the full studies highlighted here, or to arrang... ASPS Public Relations at (847) 228-9900 or media@...cus) November 23, 2009 -- Yes, Plastic Surgeons Ha...
Breaking Medicine News(10 mins):Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3
... Tuesday, May 5, 2009, 5:00 p.m. U.S. EDT , ... Cephalon, Inc . (Nasdaq: CEPH ) has scheduled...vering first quarter 2009 results for 5:00 p.m. ED...articipate in the conference call, dial 913-312-12...
... Medical Center and Anthem Blue Cross and Blue Shi...0 members in northern Nevada and surrounding areas...s, the result of a recently signed contract betwee...tive April 1, 2009, Anthem members will be able to...
...g issued by Randall Terry, founder of Operation Re....C. area Pro-life leaders and activists will gathe...egs regarding conscience for health care workers w...e proposed health reg changes for doctors. , , Pr...
...rove patient safety and enhance outcomes by enabli...tient care , , VENTURA, Calif., March 31 VivoMet...s, integrated and wearable remote patient monitori...(R) hospital patient safety suite, to create a new...
...ns with a Fast and Efficient Way to Query Their Pa...for Clinical Studies and Automation and Eliminatio..., , CARROLLTON, Ga., March 31 Greenway Medical T...lth record (EHR), practice management and interope...
... Systems (NYSE: VAR ) announced today that it wi...r 2009 following the close of regular trading on W...e followed by a teleconference available to all in...n on the conference call webcast will be available...
Other Medicine News:Health News:Saint Mary's Regional Medical Center and Anthem Blue Cross and Blue Shield Join to Enhance Access and Greater Choice in Northern Nevada 2Health News:Saint Mary's Regional Medical Center and Anthem Blue Cross and Blue Shield Join to Enhance Access and Greater Choice in Northern Nevada 3Health News:VivoMetrics Partners With OBS Medical to Develop Decision Assist Software for Remote Patient Monitoring 2Health News:VivoMetrics Partners With OBS Medical to Develop Decision Assist Software for Remote Patient Monitoring 3Health News:VivoMetrics Partners With OBS Medical to Develop Decision Assist Software for Remote Patient Monitoring 4Health News:Greenway Medical Technologies Begins Offering State-of-the-Art Research Platform, PrimeResearch 2Health News:Greenway Medical Technologies Begins Offering State-of-the-Art Research Platform, PrimeResearch 3Health News:Greenway Medical Technologies Begins Offering State-of-the-Art Research Platform, PrimeResearch 4Health News:Varian Medical Systems Schedules Second Quarter FY2009 News Release and Conference Call 2Health News:Varian Medical Systems Schedules Second Quarter FY2009 News Release and Conference Call 3
(Date:11/23/2009)...inker.comannouncesthatanewmarketresearchreportisav...&Equipment-AGlobalMarketPerspective ,, h...Systems--Equipment---A-Global-Market-Perspective.h...m_campaign=prnewswire ,, Steamsterilization...e.Steamsterilizationmarketisstableduetoregulatorye...
(Date:11/23/2009)...3/PRNewswire-USNewswire/--JubilantOrganosys,theUni...rchInstitutetodayannouncedajointventurethatwillfoc...technologiesintheareasofOncology,MetabolicDiseasea...edandleveragedpartnershipthatwillacceleratethedeve...MemorandumofUnderstandingwassignedtodayinWashingto...
(Date:11/23/2009)...endsResearchGroup,Inc.releasedWave2ofits LaunchTr...asesyndicatedmarketresearchprojecttrackingthelaunc...sixmonthsofproductavailability.Eachwaveofthereport...ogistsandqualitativeinformationfromasubsetof15.The...reasonstouse,typicalpatienttypes,productperception...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 1US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 3US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 1US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 2US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 3SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 1SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 2SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 3
...in is the First Hsp90 Inhibitor to Enter Registrat...iences,Incorporated (Nasdaq: KOSN ) today announc...ement with the U.S. Food and Drug Administration,(... pivotal Phase 3 trial,of its Hsp90 inhibitor tane... myeloma. Through the FDA,s Special Protocol Asses...
...ports Statistically Significant Point Prevalence a...ibody Response; Nabi to Host Conference ... Sept. 5 Nabi,Biopharmaceuticals (Nasdaq: NABI )...trial of NicVAX(R) (Nicotine Conjugate Vaccine), t...ional vaccine being developed to treat,nicotine ad...
Other Medicine Technology:Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 2Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 3Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 4Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 5Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 6Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 7
Specimen-ID™ for Positive Specimen Identification
IntelliDOT's Bar Code Medication Administration (BCMA) System
wCareMed™
Siemens Med Administration Check
Medicine Products: